key: cord-0827472-hb07pd98
authors: Perazzo, Hugo; Piedade, Juliana; Castro, Rodolfo; Pinto, Laura; Veloso, Valdiléa G.; Grinsztejn, Beatriz; Pereira, Gustavo; Fernandes, Flavia F.
title: COVID-19: an overview of worldwide recommendations for management of patients with liver diseases or liver transplantation
date: 2020-05-12
journal: Clin Gastroenterol Hepatol
DOI: 10.1016/j.cgh.2020.04.074
sha: 01cdc2d37bbfaf8b13ac179d1de9f3b77b9278e2
doc_id: 827472
cord_uid: hb07pd98

nan

The following authors have nothing to disclosure : The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.

We read with great interest the recent manuscript published in Clinical results of prospective studies which followed patients with chronic liver disease/liver 45 transplantation and COVID-19. Telemedicine is low-cost, widely available and well 46 accepted by patients and clinicians. 3 However, this technology might be challenged by differences in local regulations for telehealth services and/or reimbursement in each 48 country/region. 4 The risk of a flare of AIH or acute cellular rejection after liver would overcome the risk of SARS-CoV-2 infection. 5 High rates of hospital admission 51 in critical care units have been leading to a shortage of healthcare workers, beds, 52 ventilators and blood products for HCC therapies and liver transplantation during 53 COVID-19 pandemic. Thus, health authorities should consider deviations from the 54 current standard of care until definitive therapy can be delivered. 6 It is worth noting that 55 we relied this overview on current available recommendations from international and 56 national societies of gastroenterology/hepatology. However, the results of our 

Health status of liver transplanted patients during the coronavirus outbreak in Italy: a large single center experience from Milan

Telemedicine in Liver Disease and Beyond: Can the COVID-19 Crisis Lead to Action?

Applications From a Legal and Regulatory Perspective

Highlights for management of patients with Autoimmune Liver Disease during COVID-19 pandemia

ILCA Guidance for Management of HCC during COVID-19 Pandemic. International Liver Cancer Association 2020

Care of patients with liver disease during the COVID-19 pandemic